Biodesix, Inc.
BDSX · NASDAQ
Bulios Fair Price
$35.39
36.0% upside
Current Price
$26.02
According to Bulios Fair Price, BDSX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Biodesix, Inc. is a biopharmaceutical company focused on the development and commercialization of diagnostic tests for the detection and monitoring of various diseases, particularly cancer and lung diseases. The company specializes in utilizing advanced technologies such as proteomics and genetics to identify biomarkers and develop diagnostic tests that help physicians better understand the patient's condition and choose more effective treatment strategies. Biodesix is known for its innovative approaches to diagnostics and its efforts to provide personalized medicine through precise diagnostic tests. Biodesix, Inc. could be suitable for investors seeking opportunities in the biotechnology sector with an emphasis on diagnostics and personalized medicine.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Scott Hutton
Employees
334
Headquarters
Louisville
Upcoming events
Earnings
Upcoming earnings report